Uncharacterized protein

Quick info Localization Expansion Sequence features Structure Putative motif mimicry Homologs Download

Quick info

Protein:

Gene product:

OTT_1508-like deaminase, putative

Species:

Leishmania major

UniProt:

Q4Q411_LEIMA

TriTrypDb:

LmjF.33.1760 , LMJLV39_330026900 , LMJSD75_330026500

Length:

271

Localization

Secreted promastigote


Source	Evidence on protein	Close homologs
Cuervo et al.	no	yes: 0
Hassani et al.	no	yes: 0
Forrest at al. (metacyclic)	no	yes: 0
Forrest at al. (procyclic)	no	yes: 0
Silverman et al.	no	yes: 0
Pissara et al.	no	yes: 0

Secreted amastigote


Source	Evidence on protein	Close homologs
Pires et al.	no	yes: 0

Exosome


Source	Evidence on protein	Close homologs
Silverman et al.	no	yes: 0

Glycosome


Source	Evidence on protein	Close homologs
Jamdhade et al.	no	yes: 0

Predictions


Source	Evidence on protein	Close homologs
DeepLoc
SignalP6	no	yes: 0, no: 6
NetGPI	no	yes: 0, no: 6

Could not find GO cellular_component term for this entry.

Expansion

Sequence features

Q4Q411

Sequence

MSA

Disorder

Secondary

Topology

Domains

SignalP

GPI

Phosphorylations

ELMs

Structure

Predicted structure by AlphaFold2

Related structures:

AlphaFold database: Q4Q411

Putative motif mimicry


Leishmania	From	To	Domain/Motif	Score
CLV_MEL_PAP_1	37	43	PF00089	0.550
CLV_NRD_NRD_1	119	121	PF00675	0.378
CLV_NRD_NRD_1	267	269	PF00675	0.572
CLV_PCSK_KEX2_1	119	121	PF00082	0.378
CLV_PCSK_KEX2_1	267	269	PF00082	0.572
CLV_PCSK_SKI1_1	166	170	PF00082	0.383
CLV_PCSK_SKI1_1	267	271	PF00082	0.577
DOC_CYCLIN_RxL_1	160	173	PF00134	0.398
DOC_CYCLIN_yCln2_LP_2	251	257	PF00134	0.444
DOC_PP2B_LxvP_1	261	264	PF13499	0.550
DOC_USP7_MATH_1	103	107	PF00917	0.504
DOC_USP7_MATH_1	210	214	PF00917	0.403
DOC_USP7_MATH_1	238	242	PF00917	0.521
DOC_WW_Pin1_4	250	255	PF00397	0.534
DOC_WW_Pin1_4	47	52	PF00397	0.600
LIG_BRCT_BRCA1_1	48	52	PF00533	0.598
LIG_deltaCOP1_diTrp_1	141	148	PF00928	0.473
LIG_FHA_1	172	178	PF00498	0.397
LIG_FHA_1	24	30	PF00498	0.540
LIG_FHA_1	242	248	PF00498	0.549
LIG_FHA_1	9	15	PF00498	0.524
LIG_FHA_2	123	129	PF00498	0.386
LIG_LIR_Gen_1	152	159	PF02991	0.380
LIG_LIR_Nem_3	152	156	PF02991	0.384
LIG_NRP_CendR_1	268	271	PF00754	0.541
LIG_Pex14_2	207	211	PF04695	0.446
LIG_SH2_CRK	38	42	PF00017	0.614
LIG_SH2_NCK_1	6	10	PF00017	0.550
LIG_SH2_STAT5	122	125	PF00017	0.405
LIG_SH2_STAT5	225	228	PF00017	0.470
LIG_SH2_STAT5	57	60	PF00017	0.460
LIG_SH2_STAT5	72	75	PF00017	0.468
LIG_SH3_3	180	186	PF00018	0.478
LIG_SH3_3	213	219	PF00018	0.373
LIG_SH3_3	38	44	PF00018	0.577
LIG_SH3_3	45	51	PF00018	0.470
LIG_SUMO_SIM_anti_2	212	218	PF11976	0.375
LIG_SUMO_SIM_par_1	93	100	PF11976	0.443
MOD_CK1_1	106	112	PF00069	0.615
MOD_CK1_1	232	238	PF00069	0.481
MOD_CK1_1	241	247	PF00069	0.534
MOD_CK2_1	108	114	PF00069	0.619
MOD_CK2_1	122	128	PF00069	0.367
MOD_CK2_1	250	256	PF00069	0.508
MOD_DYRK1A_RPxSP_1	47	51	PF00069	0.492
MOD_GlcNHglycan	114	117	PF01048	0.560
MOD_GlcNHglycan	240	243	PF01048	0.585
MOD_GSK3_1	103	110	PF00069	0.534
MOD_GSK3_1	122	129	PF00069	0.512
MOD_GSK3_1	171	178	PF00069	0.395
MOD_GSK3_1	20	27	PF00069	0.533
MOD_GSK3_1	225	232	PF00069	0.405
MOD_GSK3_1	237	244	PF00069	0.443
MOD_N-GLC_1	126	131	PF02516	0.404
MOD_NEK2_1	224	229	PF00069	0.471
MOD_NEK2_1	29	34	PF00069	0.560
MOD_NEK2_1	8	13	PF00069	0.571
MOD_NEK2_2	75	80	PF00069	0.515
MOD_PIKK_1	128	134	PF00454	0.432
MOD_PIKK_1	171	177	PF00454	0.447
MOD_PKA_2	106	112	PF00069	0.563
MOD_PKA_2	46	52	PF00069	0.528
MOD_Plk_1	126	132	PF00069	0.404
MOD_ProDKin_1	250	256	PF00069	0.532
MOD_ProDKin_1	47	53	PF00069	0.601
MOD_SUMO_rev_2	159	169	PF00179	0.369
MOD_SUMO_rev_2	27	32	PF00179	0.546
TRG_DiLeu_BaEn_1	256	261	PF01217	0.520
TRG_DiLeu_BaLyEn_6	265	270	PF01217	0.436
TRG_ENDOCYTIC_2	38	41	PF00928	0.615
TRG_ER_diArg_1	118	120	PF00400	0.409
TRG_ER_diArg_1	267	269	PF00400	0.546
TRG_Pf-PMV_PEXEL_1	166	170	PF00026	0.383

Homologs


Protein	Taxonomy	Sequence identity	Coverage
A0A0N0P844	Leptomonas seymouri	61%	71%
A0A3Q8IHJ6	Leishmania donovani	96%	100%
A4HLN6	Leishmania braziliensis	81%	100%
A4I972	Leishmania infantum	96%	100%
E9B413	Leishmania mexicana (strain MHOM/GT/2001/U1103)	95%	100%